Discover 1,859 paid clinical trials in Virginia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Virginia provides numerous opportunities for both healthy volunteers and people with specific medical conditions to participate in paid medical research. Major research centers in Richmond, Virginia Beach, and Norfolk are actively seeking participants, offering access to innovative treatments and advanced care.
Filter
1
Filter results
Results: 1,859
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Boston MA, Richmond VA, Durham NC, Pittsburgh PA,
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT06619561
Phase2, Recruiting
Volume Reduction for Open Fracture Irrigation
for
Open Fracture
Location: Falls Church VA
Sponsor: Inova Health Care Services
Sex: All
Age: 18+
Code: NCT07437339
Recruiting
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Boston MA, New York NY, Montreal, Baltimore MD,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07491445
Phase3, Recruiting
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
for
Biochemically Recurrent Prostate Carcinoma,
Location: Stony Brook NY, Bay Shore NY, Lake Success NY,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: Male
Age: 18+
Code: NCT04423211
Phase3, Recruiting
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
for
Prostate Adenocarcinoma
Location: Baltimore MD, Bethesda MD, Richmond VA, Myrtle Beach SC,
Sponsor: Alessa Therapeutics Inc.
Sex: Male
Age: 21+
Code: NCT06257693
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
for
PSC
Location: Boston MA, New Haven CT, Montreal, Richmond VA,
Sponsor: PSC Partners Seeking a Cure
Sex: All
Age: 18 - 70+
Code: NCT06297993
Recruiting
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
for
Solid Tumor, Sarcoma, Leiomyosarcoma,
Location: Boston MA, Lake Success NY, Fairfax VA, Grand Rapids MI,
Sponsor: STORM Therapeutics LTD
Sex: All
Age: 18+
Code: NCT06975293
Phase1, Phase2, Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Halifax, Portland ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase2, Recruiting
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
for
Colorectal Neoplasms
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT05253651
Phase3, Recruiting
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
for
Non-Small Cell Lung Cancer
Location: St. John's, Rimouski, Boston MA, Levis, Stony Brook NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06357533
Phase3, Recruiting
Preoperative Bexarotene Treatment for Cushing's Disease
for
Cushing's Disease
Location: Charlottesville VA
Sponsor: University of Virginia
Sex: All
Age: 18 - 65
Code: NCT00845351
Phase1, Phase2, Recruiting
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
for
KRAS-mutant Non-small Cell Lung Cancer (NSCLC),
Location: Boston MA, Philadelphia PA, Fairfax VA, Tampa FL,
Sponsor: Kestrel Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07458347
Phase1, Recruiting
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
for
Ewing Sarcoma, Colorectal Adenocarcinoma
Location: New York NY, Philadelphia PA, Fairfax VA,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 12 - 70+
Code: NCT03715933
Phase1, Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma